<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Selected causes of unilateral or bilateral gynecomastia in children and adolescents</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Selected causes of unilateral or bilateral gynecomastia in children and adolescents</h1>
<div class="graphic"><div class="figure"><div class="ttl">Selected causes of unilateral or bilateral gynecomastia in children and adolescents</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup><colgroup width="70%"></colgroup> <tbody> <tr> <td class="subtitle1">Â </td> <td class="subtitle1">Associated clinical features</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Physiologic causes</td> </tr> <tr> <td class="indent1">Neonatal</td> <td> <ul> <li>May be associated with galactorrhea; usually resolves spontaneously within the first year of life</li> </ul> </td> </tr> <tr> <td class="indent1">Pubertal</td> <td> <ul> <li>Occurs at mid-puberty: during peak height velocity at age 12 to 14 years; pubic hair SMR stage 3 to 4; testicular volume 8 to 10 mL</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="2">Pathologic causes</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Drugs</td> </tr> <tr> <td class="indent2">Exogenous estrogen</td> <td> <ul> <li>Source of exogenous estrogen (eg, combined oral contraceptive pills, topical estrogen cream)</li> </ul> </td> </tr> <tr> <td class="indent2">Other drugs</td> <td> <ul> <li>History of exposure to drug or other substances associated with gynecomastia (refer to UpToDate content on drugs that cause gynecomastia)</li> </ul> </td> </tr> <tr> <td class="subtitle3_left" colspan="2">Hypogonadism</td> </tr> <tr> <td class="indent2" colspan="2">Primary (hypergonadotropic)</td> </tr> <tr> <td class="indent3"> <ul> <li>Klinefelter syndrome</li> </ul> </td> <td> <ul> <li>Tall, thin body habitus; small firm testes in pubertal-aged males</li> </ul> </td> </tr> <tr> <td class="indent3"> <ul> <li>Cryptorchidism</li> </ul> </td> <td> <ul> <li>One or both testes not within the scrotum (or history of testis that is not within the scrotum)</li> </ul> </td> </tr> <tr> <td class="indent3"> <ul> <li>Defect in testosterone synthesis (eg, 17-ketosteroid reductase deficiency)</li> </ul> </td> <td> <ul> <li>Atypical genitalia; undervirilization</li> </ul> </td> </tr> <tr> <td class="indent3"> <ul> <li>Acquired primary hypogonadism</li> </ul> </td> <td> <ul> <li>History of testicular insult or injury (eg, surgery, radiation, systemic illness, etc)</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="2">Secondary (hypogonadotropic)</td> </tr> <tr> <td class="indent3"> <ul> <li>Acquired secondary hypogonadism</li> </ul> </td> <td> <ul> <li>Insult to hypothalamic-pituitary axis (eg, surgery, radiation, trauma, etc)</li> </ul> </td> </tr> <tr> <td class="indent3"> <ul> <li>Hyperprolactinemia</li> </ul> </td> <td> <ul> <li>Galactorrhea</li> </ul> </td> </tr> <tr> <td class="subtitle3_left" colspan="2">Tumors</td> </tr> <tr> <td class="indent2">Testicular cancer (Leydig or Sertoli cell)</td> <td> <ul> <li>Testicular mass; increased risk with history of cryptorchidism (any testicular cancer); increased risk in Peutz-Jeghers syndrome (Sertoli cell tumors)</li> </ul> </td> </tr> <tr> <td class="indent2">Feminizing adrenal tumor</td> <td> <ul> <li>Abdominal mass</li> </ul> </td> </tr> <tr> <td class="indent2">Lactotroph adenoma (prolactinoma)</td> <td> <ul> <li>Galactorrhea, hypogonadism, vision problems, headaches</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="2">hCG-producing tumors</td> </tr> <tr> <td class="indent3"> <ul> <li>Testicular (germ cell)</li> </ul> </td> <td> <ul> <li>Testicular mass; increased risk with history of cryptorchidism</li> </ul> </td> </tr> <tr> <td class="indent3"> <ul> <li>Extragonadal germ cell tumor (eg, mediastinal, retroperitoneal, intracranial)</li> </ul> </td> <td> <ul> <li>May be detected with chest or abdominal imaging</li> </ul> </td> </tr> <tr> <td class="indent3"> <ul> <li>Nontrophoblastic hCG-producing tumor</li> </ul> </td> <td> <ul> <li>May be detected with imaging (chest, abdomen, brain)</li> </ul> </td> </tr> <tr> <td class="subtitle3_left" colspan="2">Other causes</td> </tr> <tr> <td class="indent2">Chronic liver or kidney disease/malnutrition</td> <td> <ul> <li>Underweight; findings associated with chronic liver or kidney disease (eg, hepatomegaly, edema, etc)</li> </ul> </td> </tr> <tr> <td class="indent2">Hyperthyroidism</td> <td> <ul> <li>Goiter, accelerated growth, weight loss, ophthalmopathy, tachycardia, increased appetite, tremor</li> </ul> </td> </tr> <tr> <td class="indent2">Aromatase excess syndrome</td> <td> <ul> <li>Accelerated early linear growth, prepubertal gynecomastia, testicular failure</li> </ul> </td> </tr> <tr> <td class="indent2">Androgen resistance (eg, partial androgen insensitivity)</td> <td> <ul> <li>Atypical genitalia; undervirilization; muscle fasciculations, weakness, and calf hypertrophy (X-linked spinal and bulbar muscular atrophy)</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="2">Congenital adrenal hyperplasia</td> </tr> <tr> <td class="indent3"> <ul> <li>11-beta-hydroxylase deficiency</li> </ul> </td> <td> <ul> <li>Premature adrenarche, early puberty, accelerated linear growth, hypertension</li> </ul> </td> </tr> <tr> <td class="indent3"> <ul> <li>3-beta-hydroxysteroid dehydrogenase deficiency</li> </ul> </td> <td> <ul> <li>Atypical genitalia, undervirilization</li> </ul> </td> </tr> <tr> <td class="indent3"> <ul> <li>Late-onset 21-hydroxylase deficiency</li> </ul> </td> <td> <ul> <li>Premature adrenarche with advanced bone age, accelerated linear growth during childhood, acne</li> </ul> </td> </tr> <tr> <td class="indent2">Ovotesticular difference of sex development (previously "true hermaphroditism")</td> <td> <ul> <li>Atypical genitalia (presence of both ovarian follicular and testicular tubular tissue in a single individual); undervirilization</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">SMR: sexual maturity rating (Tanner stage); hCG: human chorionic gonadotropin.</div><div class="graphic_reference">References:
    <ol>
<li>Braunstein GD. Gynecomastia. N Engl J Med 1993; 328:490.</li>
<li>Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med 2007; 357:1229.</li>
<li>Ma NS, Geffner ME. Gynecomastia in prepubertal and pubertal men. Curr Opin Pediatr 2008; 20:465.</li>
</ol></div><div id="graphicVersion">Graphic 109486 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
